Treatment of Decompression Sickness in Swine with Intravenous Perfluorocarbon Emulsion

Aviation Space and Environmental Medicine

Volumn 75, Issue 4 SEC. I, 2004, Pages 301-305

  Dromsky, David M ^a,b   Spiess, Bruce D ^a   Fahlman, Andreas ^a   Temple, Diana J ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

DCS; Perfluorochemicals; Saturation diving; Steroids

Indexed keywords

FLUOROCARBON; PERFLUOROOCTYL BROMIDE;

ADJUVANT THERAPY; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECOMPRESSION SICKNESS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EMULSION; EXPERIMENTAL MODEL; LOGISTIC REGRESSION ANALYSIS; MALE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOMES RESEARCH; OXYGEN BREATHING; OXYGEN THERAPY; RESPIRATORY TRACT DISEASE; SWINE;

ANIMALS; DECOMPRESSION SICKNESS; EMULSIONS; FLUOROCARBONS; MALE; RANDOM ALLOCATION; SWINE;

ANIMALIA; SUS SCROFA;

EID: 1842527154     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Catron PW, Flynn ET Jr, Yaffe L, et al. Morphological and physiological responses of the lungs of dogs to acute decompression. J Appl Physiol 1984; 57:467-74.
2. Clark L, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152:1755-7.
3. Cole C, Chamberlain D, Burch B, et al. Pathological effects of explosive decompression to 30 mmHg. J Appl Physiol 1953; 6:96-104.
4. Dromsky D, Toner C, Survanshi S, et al. Natural history of severe decompression sickness after rapid ascent from air saturation in a porcine model. J Appl Physiol 2000; 89:791-8.
5. 2 biochemical decompression in pigs. J Appl Physiol 2001; 91:2720-9.
6. Faithful NS, Weers JG. Perflurocarbon compounds. Vox Sang 1998; 74(Suppl 2):243-8.
7. Flaim S, Hazard D, Hogan J, Peters RM. Characterization and mechanism of side-effects of oxygent ht (highly concentrated fluorocarbon emulsion) in swine. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:1511-5.
8. Glogar DH, Kloner RA, Muller J, et al. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 1981; 211:1439-41.
9. Herren JI, Kunzelman KS, Vocelka C, et al. Angiographic and histological evaluation of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism. Stroke 1998; 29:2396-403.
10. Hosmer W, Lemeshow S. Applied logistic regression. New York: Wiley; 1989.
11. Lynch PR, Krasner LJ, Vinciquerra T, Shaffer TH. Effects of intravenous perfluorocarbon and oxygen breathing on acute decompression sickness in the hamster. Undersea Biomed Res 1989; 16:275-81.
12. McKiennan R. Exercise and hemodynamic studies in swine. In: Stanton H, ed. Swine in cardiovascular research. Boca Raton, FL: CRC Press; 1986; 2:105-120.
13. Muth CM, Shank CS, Larsen B. Severe diving accidents: Physiopathology, symptoms, therapy. Anaesthesist 2000; 49:302-16.
14. Novotny JA, Bridgewater BJ, Himm JF, Homer LD. Quantifying the effect of intravascular perfluorocarbon on xenon elimination from canine muscle. J Appl Physiol 1993; 74:1356-60.
15. Padnick LB, Linsenmeier RA, Goldstick TK. Perfluorocarbon emulsion improves oxygenation of the cat primary visual cortex. J Appl Physiol 1999; 86:1497-504.
16. Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG. Modification of cerebral ischemia with Fluosol. Stroke 1985; 16:38-43.
17. Spiess BD, Braverman B, Woronowicz AW, Ivankovich AD. Protection from cerebral air emboli with perfluorocarbons in rabbits. Stroke 1986; 17:1146-9.
18. Spiess BD, McCarthy RJ, Tuman KJ, et al. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). Undersea Biomed Res 1988; 15:31-7.
19. Swindle M. Swine as models in biomedical research. Ames, Iowa: Iowa State University Press; 1992:185-97.
20. Van Rensselaer H. The pathology of the caisson disease. Med Rec NY 1891; 40:141-150; 178-182.
21. Vocelka C, Spiess B, Soltow L, et al. A perfluorocarbon emulsion prime additive improves the electroencephalogram and cerebral blood flow at the initiation of cardiopulmonary bypass. J Extra Corpor Technol 1995; 27:6-10.